Clinical, bacteriological and demographic characteristics of infective endocarditis
Article Sidebar
Main Article Content
Abstract
Introduction: infective endocarditisis a disease with a diversity of clinical presentation, high morbidity and mortality, a weight of advances in diagnosis and in the efficacy of antibiotics.
Objectives: to describe the clinical, bacteriological, demographic and associated mortality characteristics of patients with infective endocarditis, admitted to the Hospital Nacional, Itauguá-Paraguay from 2016 to 2018.
Methodology: observational, descriptive, cross-sectional study of patients with infective endocarditisis, according to modified Duke criteria.
Results: 50 patients were included; age 43 ± 16 years, 70 % were men, the origin (38 %) of the Departamento Central, 42 entered for fever (84 %); It was found that 44 (88 %) of the cases on native valves, the most affected were the mitral 20 (46 %) followed by the aortic 16 (36 %), with Staphylococcus aureus (36 %) being the prevalent germ in this group, in addition 6 (12 %) of the cases on prosthetic valves, being in this group Staphylococcus spp (46 %) the prevalent germ, it was found that they were catheter carriers for hemodialysis 8 (16 %) of the patients, 17 (39 %) with blood cultures negatives.
They presented complications (52 %) of these were cardiac (24 %), neurological (18 %), pulmonary embolism (6 %), renal (4 %) and a fatal outcome (44 %) of the cases was found, being those with the worst prognosis neurological complications.
Conclusions: infective endocarditisis, according to the findings, continues to be a frequent disease with serious complications and high deaths, a challenge; Identification of risk factors to open a scenario in which it would be important to work and promote preventive measures, insist on the use of arteriovenous fistulas for hemodialysis in outpatients. The most frequent germ Staphylococcus spp.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Conde Mercado JM, Camacho Limas CP, Quintana Cuellar M, De La Torre Saldaña VA, Brito CA, Alonso Bello CD, et al. Endocarditis infecciosa. Rev Hosp Jua Mex. 2017;84(3):143–66.
Pigretti S, Zurrú MC, Arias A, Parcerisa F, Luzzi A, Belziti C. Endocarditis infecciosa :¿afectan su pronóstico las complicaciones neurológicas ?. Medicina (Buenos Aires). 2017;77(2):89–94.
Flores P, González N, Betancourt P, Berho J, Astudillo C, García C, et al. Endocarditis Infecciosa : caracterización clínica de la enfermedad . Revisión de casos de los últimos 5 años Infective endocarditis : clinical experience in the last five years. Rev Chil Cardiol. 2017;36(1):34–40.
Kuster F. Guías Europeas 2015 de endocarditis infecciosa . Nuevos desafíos, nuevas esperanzas. Rev Urug Cardiol. 2016;31(2):256–60.
Álvez González JMSL, Sánchez Lastres JM. Faringo-amigdalitis aguda. Aeped [Internet]. 2015;1:1–4. Available from: https://www.aeped.es/sites/default/files/documentos/faringoamigdalitis.pdf
Horacio J, Mtsac C. Consenso de endocarditis infecciosa. Rev Argentina Cardiol. 2016;84(Suppl 1):1–49.
Sénior JM, Gándara Ricardo JA. Endocarditis infecciosa. IATREIA. 2015;28(4):456–71.
Tornos P, Ferna N. Epidemiología de la endocarditis infecciosa en España en los últimos 20 años. Rev Esp Cardiol. 2017;66(9):728–33.
Endocarditis infecciosa. Rev. Argent. Cardiol. 2003; 71 (supl. 2): 60-64. Disponible en: https://www.sac.org.ar/wp-content/uploads/2014/04/cg4-c1.pdf
Real Delor R, Fridman D’ Alessandro V. Abordaje clínico de adultos con fiebre prolongada. Rev Med La Paz. 2016;22(2):18–28.
Fernández Hidalgo N, Tornos Mas P. Epidemiología de la endocarditis infecciosa en España en los últimos 20 años. Rev Esp Cardiol. 2013;66(9):728–33.
Rosso F, Perafán Bautista PE, Carrillo Gómez DC, Ramos Amézquita MH, Cedano Rincón J. Infección relacionada con los dispositivos cardiovasculares. Rev Colomb Cardiol. 2016;23(6):508–13.
Manzur F, Olivo C. Indicaciones básicas para la realización de ecocardiografía-Doppler-color Basic indications for the performance of color Doppler echocardiography. Rev Colomb Cardiol. 2005;12(1):11–9.
Varona JF. Complicaciones neurológicas como manifestación inicial de endocarditis infecciosa. An Med Interna. 2007;24(9):439–41.
Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65(19):2070–6.
Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in Infective Endocarditis in California and New York State, 1998-2013. 2017;317(16):1652–60.
Ambrosioni J, Hernandez Meneses M, Téllez A, Pericàs J, Falces C, Tolosana J, et al. The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century. Curr Infect Dis Rep. 2017;19(5):21.
Cortés C, Casabé J, Favaloro R, Raffaelli H, Dulbecco E, Abud J, et al. Insuficiencia Aórtica Aguda Por Endocarditis Infecciosa. Med (Buenos Aires). 2017;77(5):373–81.
Pigretti S, Zurrú MC, Arias A. Endocarditis infecciosa: manifestaciones neurológicas. Med (Buenos Aires). 2017;77(2):89–94.
Kuster F, Kuster F. Guías Europeas 2015 de endocarditis infecciosa . Nuevos desafíos , nuevas esperanzas. Rev Urug Cardiol. 2016;31(2):256–60.
Chen SJ, Liu CJ, Chao TF, Wang KL, Wang FD, Chen TJ, et al. Dental Scaling and Risk Reduction in Infective Endocarditis: A Nationwide Population-Based Case-Control Study. Can J Cardiol. 2013;29(4):429–33.
Strady C, Euvrard E, Agrinier N, Thomas D, Hoen B, Moby V, et al. Oral streptococcal endocarditis, oral hygiene habits and recent dental procedures: a case-control study. Clin Infect Dis. 2017;64(1678):1–23.
Østergaard L, Valeur N, Wang A, Bundgaard H, Aslam M, Gislason G, et al. Incidence of infective endocarditis in patients considered at moderate risk. Eur Heart J. 2019;40(17):1355–61.
Castillo FJ, Anguita M, Castillo JC, Ruiz M, Mesa D, Suárez de Lezo J. Changes in Clinical Profile, Epidemiology and Prognosis of Left-sided Native-valve Infective Endocarditis Without Predisposing Heart Conditions. Rev Española Cardiol-.2015;68(5):445–8.
Conde mercado JM, Camacho Limas CP, Quintana Cuellar M, Torre Saldaña VAD La, Brito CA, Alonso Bello CD. Endocarditis infecciosa. Rev Hosp Jua Mex. 2017;84(3):143–66.
Zegri Reiriz I, de Alarcón A, Muñoz P, Martínez Sellés M, González Ramallo V, Miro JM, et al. Infective endocarditis in patients with bicuspid aortic valve or mitral valve prolapse. J Am Coll Cardiol. 2018;71(24):2731–40.
Alberti MO, Hindler JA, Humphries RM. Antimicrobial susceptibilities of abiotrophia defectiva, granulicatella adiacens, and granulicatella elegans. Antimicrob Agents Chemother. 2016;60(3):1411–20.
Tellez A, Llopis J, Falces C, Almela M, Garcia De La María C, Hernández Meneses M, et al. Epidemiology, clinical features, and outcome of infective endocarditis due to abiotrophia species and granulicatella species: Report of 76 Cases, 2000-2015. Clin Infect Dis. 2018;66(1):104–11.
Cahill TJ, Prendergast BD. Infective endocarditis. Lancet [Internet]. 2016;387(10021):882–93. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673615000677
Loughrey PB, Armstrong D, Lockhart CJ. Classical eye signs in bacterial endocarditis. Qjm. 2015;108(11):909–10.
Hudziak AD, Parma R, Gocoł R, Żak A. Infectious endocarditis after valve-in-valve transcatheter aortic valve implantation: reoperative treatment of infectious endocarditis. Kardiol Pol. 2020;78(1):84–85.
Pardinas Liergo MJ, Alarcón Sotelo A, Ramírez Angulo C, Rodríguez Weber F, Díaz Greene EJ. Probabilidad de éxito de obtener un hemocultivo positivo. Med Interna Mex. 2017;33(1):28–40.
Kirn TJ, Weinstein MP. Update on blood cultures: How to obtain, process, report, and interpret. Clin Microbiol Infect. 2013;19(6):513–20.
Sánchez E, Gutiérrez C. Evolución y letalidad por endocarditis infecciosa en pacientes atendidos en el Hospital Nacional Dos de Mayo. An la Fac Med. 2013;67(2):125.
Kazelian LR, Vidal LA, Neme R, Gagliardi JA. Endocarditis infecciosa activa: 152 casos. Med (Buenos Aires) 2012; 72: 109-114.
Matajari T, Felez I, Lacambra M, Azuaza M, Alvarez R, Iñigo P. Endocarditis bacteriana por SAMR en paciente portador de cateter venoso central para hemodiálisis: uso de daptomicina. NefroPlus. 2010;3(2):41–5.
Oyonarte M, Montagna R, Braun S, Rojo P, Jara JL, Cereceda M, et al. Endocarditis infecciosa: características clínicas, complicaciones y mortalidad en 506 pacientes y factores pronósticos de sobrevida a 10 años (1998-2008). estudio cooperativo nacional en endocarditis infecciosa en Chile (ECNEI-2). Rev Med Chil. 2012;140(12):1517–28.
Sociedad Argentina de Infectología, Casbé JH, dir. Consenso de endocarditis infecciosas. Rev. argent. cardiol. 2016;84 Supl. Disponible en: https://www.sac.org.ar/wp-content/uploads/2017/01/consenso-de-endocarditis-2017.pdf
Khan A, Aslam A, Satti KN, Ashiq S. Infective endocarditis post-trans catheter aortic valve implantation (TAVI), microbiological profile and clinical outcomes: A systematic review. PLoS One. 2020;15(1):e0225077.
Coronel J, Ruiz Díaz N, Shin YI. Endocarditis Infecciosa en pacientes del Hospital de Clínicas. Med. actual 2011;12(1):5-8.